Stem cell death and survival in heart regeneration and repair

Apoptosis

Volumn 21, Issue 3, 2016, Pages 252-268

  Abdelwahid, Eltyeb ^a   Kalvelyte, Audrone ^b   Stulpinas, Aurimas ^b   De Carvalho, Katherine Athayde Teixeira ^c   Guarita Souza, Luiz Cesar ^d   Foldes, Gabor ^e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b VILNIUS UNIVERSITY   (Lithuania)

^c INSTITUTO DE PESQUISA PELÉ PEQUENO PRÍNCIPE   (Brazil)

^d PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^e NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Apoptosis; Cell death; Heart; Regeneration; Stem cells; Therapy

Indexed keywords

JANUS KINASE; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SYNAPTOPHYSIN;

APOPTOSIS; CELL DEATH; CELL SELECTION; CELL SURVIVAL; CELLS; EXOSOME; GENE THERAPY; HEART; HEART MUSCLE; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR; VASCULARIZATION; ANIMAL; BIOENGINEERING; CARDIAC MUSCLE CELL; HEART INFARCTION PREVENTION; METABOLISM; MULTIPOTENT STEM CELL; MYOCARDIAL INFARCTION; PATHOLOGY; PHYSIOLOGY; PLURIPOTENT STEM CELL; PROCEDURES; REGENERATION; TRANSPLANTATION;

ANIMALS; APOPTOSIS; BIOENGINEERING; CELL SURVIVAL; EXOSOMES; GENETIC THERAPY; HEART; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MICRORNAS; MULTIPOTENT STEM CELLS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; REACTIVE OXYGEN SPECIES; REGENERATION; SIGNAL TRANSDUCTION;

EID: 84957438156     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-015-1203-4     Document Type: Review

References (216)

1. Abdelwahid E, Siminiak T, Guarita-Souza LC et al (2011) Stem cell therapy in heart diseases: a review of selected new perspectives, practical considerations and clinical applications. Curr Cardiol Rev 7:201-212
2. Passier R, van Laake LW, Mummery CL (2008) Stem-cell-based therapy and lessons from the heart. Nature 453:322-329
3. Check E (2004) Cardiologists take heart from stem-cell treatment success. Nature 428:880
4. Wu X, Ding S, Ding Q, Gray NS, Schultz PG (2004) Small molecules that induce cardiomyogenesis in embryonic stem cells. J Am Chem Soc 126:1590-1591
5. Zhang J, Wilson GF, Soerens AG et al (2009) Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 104:e30-41
6. Orlic D, Kajstura J, Chimenti S et al (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410:701-705
7. Strauer BE, Brehm M, Zeus T et al (2002) Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106:1913-1918
8. Jackson KA, Majka SM, Wang H et al (2001) Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Investig 107:1395-1402
9. Badorff C, Brandes RP, Popp R et al (2003) Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 107:1024-1032
10. Rupp S, Badorff C, Koyanagi M et al (2004) Statin therapy in patients with coronary artery disease improves the impaired endothelial progenitor cell differentiation into cardiomyogenic cells. Basic Res Cardiol 99:61-68
11. Zhang J, Wu Y, Chen A, Zhao Q (2015) Mesenchymal stem cells promote cardiac muscle repair via enhanced neovascularization. Cell Physiol Biochem 35:1219-1229
12. Gnecchi M, He H, Liang OD et al (2005) Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11:367-368
13. Gnecchi M, He H, Noiseux N et al (2006) Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20:661-669
14. Haider H, Ashraf M (2005) Bone marrow stem cell transplantation for cardiac repair. Am J Physiol Heart Circ Physiol 288:H2557-2567
15. Kofidis T, de Bruin JL, Yamane T et al (2004) Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration. Stem Cells 22:1239-1245
16. Li RK, Jia ZQ, Weisel RD, Merante F, Mickle DA (1999) Smooth muscle cell transplantation into myocardial scar tissue improves heart function. J Mol Cell Cardiol 31:513-522
17. Li RK, Weisel RD, Mickle DA et al (2000) Autologous porcine heart cell transplantation improved heart function after a myocardial infarction. J Thorac Cardiovasc Surg 119:62-68
18. Singla DK, Hacker TA, Ma L et al (2006) Transplantation of embryonic stem cells into the infarcted mouse heart: formation of multiple cell types. J Mol Cell Cardiol 40:195-200
19. Singla DK, Lyons GE, Kamp TJ (2007) Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. Am J Physiol Heart Circ Physiol 293:H1308-1314
20. Dimmeler S, Zeiher AM, Schneider MD (2005) Unchain my heart: the scientific foundations of cardiac repair. J Clin Investig 115:572-583
21. Beltrami AP, Urbanek K, Kajstura J et al (2001) Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344:1750-1757
22. Bergmann O, Zdunek S, Felker A et al (2015) Dynamics of cell generation and turnover in the human heart. Cell 161:1566-1575
23. Hamano K, Li TS, Kobayashi T et al (2002) Therapeutic angiogenesis induced by local autologous bone marrow cell implantation. Ann thorac Surg 73:1210-1215
24. Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD (2002) Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105:93-98
25. Geng YJ (2003) Molecular mechanisms for cardiovascular stem cell apoptosis and growth in the hearts with atherosclerotic coronary disease and ischemic heart failure. Ann N Y Acad Sci 1010:687-697
26. Robey TE, Saiget MK, Reinecke H, Murry CE (2008) Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol 45:567-581
27. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE (2001) Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 33:907-921
28. Yang YJ, Qian HY, Huang J et al (2008) Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts. Eur Heart J 29:1578-1590
29. Lu WN, Lu SH, Wang HB et al (2009) Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel. Tissue Eng Part A 15:1437-1447
30. Young PP, Schafer R (2015) Cell-based therapies for cardiac disease: a cellular therapist's perspective. Transfusion 55:441-451; quiz 440
31. Kochupura PV, Azeloglu EU, Kelly DJ et al (2005) Tissue-engineered myocardial patch derived from extracellular matrix provides regional mechanical function. Circulation 112:I144-149
32. Sancricca C, Mirabella M, Gliubizzi C, Broccolini A, Gidaro T, Morosetti R (2010) Vessel-associated stem cells from skeletal muscle: From biology to future uses in cell therapy. World J Stem Cells 2:39-49
33. Pannerec A, Marazzi G, Sassoon D (2012) Stem cells in the hood: the skeletal muscle niche. Trends Mol Med 18:599-606
34. Akhmedov AT, Marin-Garcia J (2013) Myocardial regeneration of the failing heart. Heart Fail Rev 18:815-833
35. Francisco J, Cunha R, Simeoni R et al (2013) Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors. J Biomed Sci Eng 6:1178-1185
36. Kofidis T, deBruin JL, Tanaka M et al (2005) They are not stealthy in the heart: embryonic stem cells trigger cell infiltration, humoral and T-lymphocyte-based host immune response. Eur J Cardio Thorac Surg 28:461-466
37. Gharaibeh B, Lavasani M, Cummins JH, Huard J (2011) Terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and host cells. Stem Cell Res Ther 2:31
38. Mylotte LA, Duffy AM, Murphy M et al (2008) Metabolic flexibility permits mesenchymal stem cell survival in an ischemic environment. Stem Cells 26:1325-1336
39. Stamm C, Westphal B, Kleine HD et al (2003) Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361:45-46
40. Katritsis DG, Sotiropoulou PA, Karvouni E et al (2005) Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc Interv 65:321-329
41. Miyahara Y, Nagaya N, Kataoka M et al (2006) Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 12:459-465
42. Silva GV, Litovsky S, Assad JA et al (2005) Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111:150-156
43. Quevedo HC, Hatzistergos KE, Oskouei BN et al (2009) Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci USA 106:14022-14027
44. Makkar RR, Price MJ, Lill M et al (2005) Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarction. J Cardiovasc Pharmacol Ther 10:225-233
45. Yang ZJ, Ma DC, Wang W et al (2006) Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction. Gene Ther 13:1564-1568
46. Pasha Z, Wang Y, Sheikh R, Zhang D, Zhao T, Ashraf M (2008) Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res 77:134-142
47. Chen SL, Fang WW, Ye F et al (2004) Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94:92-95
48. Williams AR, Trachtenberg B, Velazquez DL et al (2011) Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling. Circ Res 108:792-796
49. Trachtenberg B, Velazquez DL, Williams AR et al (2011) Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy. Am Heart J 161:487-493
50. Fukushima S, Campbell NG, Coppen SR et al (2011) Quantitative assessment of initial retention of bone marrow mononuclear cells injected into the coronary arteries. J Heart Lung Transpl 30:227-233
51. Sirmenis R, Kraniauskas A, Jarasiene R, Baltriukiene D, Kalvelyte A, Bukelskiene V (2011) Recovery of infarcted myocardium in an in vivo experiment. Medicina (Kaunas) 47:607-615
52. Fukushima S, Sawa Y, Suzuki K (2013) Choice of cell-delivery route for successful cell transplantation therapy for the heart. Futur Cardiol 9:215-227
53. Poynter JA, Herrmann JL, Manukyan MC et al (2011) Intracoronary mesenchymal stem cells promote postischemic myocardial functional recovery, decrease inflammation, and reduce apoptosis via a signal transducer and activator of transcription 3 mechanism. J Am Coll Surg 213:253-260
54. Huang H, He J, Teng X et al (2013) Combined intrathymic and intravenous injection of mesenchymal stem cells can prolong the survival of rat cardiac allograft associated with decrease in miR-155 expression. J Surg Res 185:896-903
55. Tano N, Narita T, Kaneko M et al (2014) Epicardial placement of mesenchymal stromal cell-sheets for the treatment of ischemic cardiomyopathy; in vivo proof-of-concept study. Mol Ther 22:1864-1871
56. Menasche P, Vanneaux V, Fabreguettes JR et al (2015) Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience. Eur Heart J 36:743-750
57. Campbell NG, Suzuki K (2012) Cell delivery routes for stem cell therapy to the heart: current and future approaches. J Cardiovasc Transl Res 5:713-726
58. Chen K, Keaney JF Jr (2012) Evolving concepts of oxidative stress and reactive oxygen species in cardiovascular disease. Curr Atheroscler Rep 14:476-483
59. Liu Z, Wang H, Wang Y et al (2012) The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment. Biomaterials 33:3093-3106
60. Don CW, Murry CE (2013) Improving survival and efficacy of pluripotent stem cell-derived cardiac grafts. J Cell Mol Med 17:1355-1362
61. Li X, Liu X, Tan Y, Tran V, Zhang N, Wen X (2012) Improve the viability of transplanted neural cells with appropriate sized neurospheres coated with mesenchymal stem cells. Med Hypotheses 79:274-277
62. You D, Waeckel L, Ebrahimian TG et al (2006) Increase in vascular permeability and vasodilation are critical for proangiogenic effects of stem cell therapy. Circulation 114:328-338
63. Ye Z, Zhou Y, Cai H, Tan W (2011) Myocardial regeneration: Roles of stem cells and hydrogels. Adv Drug Deliv Rev 63:688-697
64. Garzoni LR, Rossi MI, de Barros AP et al (2009) Dissecting coronary angiogenesis: 3D co-culture of cardiomyocytes with endothelial or mesenchymal cells. Exp Cell Res 315:3406-3418
65. Bhang SH, Cho SW, La WG et al (2011) Angiogenesis in ischemic tissue produced by spheroid grafting of human adipose-derived stromal cells. Biomaterials 32:2734-2747
66. Uemura R, Xu M, Ahmad N, Ashraf M (2006) Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 98:1414-1421
67. Pfeffer MA, Braunwald E (1990) Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81:1161-1172
68. Fishbein MC, Maclean D, Maroko PR (1978) Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution. Am J Pathol 90:57-70
69. Li L, Bennett SA, Wang L (2012) Role of E-cadherin and other cell adhesion molecules in survival and differentiation of human pluripotent stem cells. Cell Adh Migr 6:59-70
70. Xu Y, Zhu X, Hahm HS et al (2010) Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules. Proc Natl Acad Sci USA 107:8129-8134
71. Ohgushi M, Matsumura M, Eiraku M et al (2010) Molecular pathway and cell state responsible for dissociation-induced apoptosis in human pluripotent stem cells. Cell Stem Cell 7:225-239
72. Chen G, Hou Z, Gulbranson DR, Thomson JA (2010) Actin-myosin contractility is responsible for the reduced viability of dissociated human embryonic stem cells. Cell Stem Cell 7:240-248
73. Bollini S, Riley PR, Smart N (2015) Thymosin beta4: multiple functions in protection, repair and regeneration of the mammalian heart. Expert Opin Biol Ther 15(Suppl 1):S163-174
74. Huang HL, Hsing HW, Lai TC et al (2010) Trypsin-induced proteome alteration during cell subculture in mammalian cells. J Biomed Sci 17:36
75. Gerard C, Forest MA, Beauregard G, Skuk D, Tremblay JP (2012) Fibrin gel improves the survival of transplanted myoblasts. Cell Transpl 21:127-137
76. Ma J, Holden K, Zhu J, Pan H, Li Y (2011) The application of three-dimensional collagen-scaffolds seeded with myoblasts to repair skeletal muscle defects. J Biomed Biotechnol 2011:812135
77. Forte G, Pagliari S, Pagliari F, Ebara M, Di Nardo P, Aoyagi T (2013) Towards the generation of patient-specific patches for cardiac repair. Stem Cell Rev 9:313-325
78. Siepe M, Golsong P, Poppe A et al (2011) Scaffold-based transplantation of akt1-overexpressing skeletal myoblasts: functional regeneration is associated with angiogenesis and reduced infarction size. Tissue Eng Part A 17:205-212
79. Sart S, Ma T, Li Y (2014) Preconditioning stem cells for in vivo delivery. Biores Open Access 3:137-149
80. Giordano FJ (2005) Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Investig 115:500-508
81. Song H, Cha MJ, Song BW et al (2010) Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex. Stem Cells 28:555-563
82. Brown DI, Griendling KK (2015) Regulation of signal transduction by reactive oxygen species in the cardiovascular system. Circ Res 116:531-549
83. Droge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82:47-95
84. Ryter SW, Kim HP, Hoetzel A et al (2007) Mechanisms of cell death in oxidative stress. Antioxid Redox Signal 9:49-89
85. Ushio-Fukai M, Rehman J (2014) Redox and metabolic regulation of stem/progenitor cells and their niche. Antioxid Redox Signal 21:1587-1590
86. Tan SC, Gomes RS, Yeoh KK et al (2015) Preconditioning of cardiosphere-derived cells with hypoxia or prolyl-4-hydroxylase inhibitors increases stemness and decreases reliance on oxidative metabolism. Cell Transpl.
87. Rodrigues M, Turner O, Stolz D, Griffith LG, Wells A (2012) Production of reactive oxygen species by multipotent stromal cells/mesenchymal stem cells upon exposure to fas ligand. Cell Transpl 21:2171-2187
88. Reinecke H, Murry CE (2000) Transmural replacement of myocardium after skeletal myoblast grafting into the heart. Too much of a good thing? Cardiovasc Pathol 9:337-344
89. Reinecke H, Murry CE (2003) Cell grafting for cardiac repair. Methods Mol Biol 219:97-112
90. Wollert KC, Meyer GP, Lotz J et al (2004) Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364:141-148
91. Suzuki K, Murtuza B, Beauchamp JR et al (2004) Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart. Circulation 110:II219-II224
92. Suzuki K, Murtuza B, Beauchamp JR et al (2004) Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J 18:1153-1155
93. Murtuza B, Suzuki K, Bou-Gharios G et al (2004) Transplantation of skeletal myoblasts secreting an IL-1 inhibitor modulates adverse remodeling in infarcted murine myocardium. Proc Natl Acad Sci USA 101:4216-4221
94. Rowart P, Erpicum P, Detry O et al (2015) Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury. J Immunol Res 2015:602597
95. De Miguel MP, Fuentes-Julian S, Blazquez-Martinez A et al (2012) Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr Mol Med 12:574-591
96. Teramura Y, Asif S, Ekdahl KN, Nilsson B (2015) Cell surface engineering for regulation of immune reactions in cell therapy. Adv Exp Med Biol 865:189-209
97. Guo J, Zheng D, Li WF, Li HR, Zhang AD, Li ZC (2014) Insulin-like growth factor 1 treatment of MSCs attenuates inflammation and cardiac dysfunction following MI. Inflammation 37:2156-2163
98. Choi HJ, Seon MR, Lim SS, Kim JS, Chun HS, Park JH (2008) Hexane/ethanol extract of Glycyrrhiza uralensis licorice suppresses doxorubicin-induced apoptosis in H9c2 rat cardiac myoblasts. Exp Biol Med 233:1554-1560
99. Madonna R, Taylor DA, Geng YJ et al (2013) Transplantation of mesenchymal cells rejuvenated by the overexpression of telomerase and myocardin promotes revascularization and tissue repair in a murine model of hindlimb ischemia. Circ Res 113:902-914
100. Smith MI, Huang YY, Deshmukh M (2009) Skeletal muscle differentiation evokes endogenous XIAP to restrict the apoptotic pathway. PLoS ONE 4:e5097
101. Zhang L, Xing D, Liu L, Gao X, Chen M (2007) TNFalpha induces apoptosis through JNK/Bax-dependent pathway in differentiated, but not naive PC12 cells. Cell Cycle 6:1479-1486
102. Luo W, Cao J, Li J, He W (2008) Adipose tissue-specific PPARgamma deficiency increases resistance to oxidative stress. Exp Gerontol 43:154-163
103. Cecchi C, Pensalfini A, Liguri G et al (2008) Differentiation increases the resistance of neuronal cells to amyloid toxicity. Neurochem Res 33:2516-2531
104. Kalvelyte A, Krestnikova N, Stulpinas A et al (2013) Long-term muscle-derived cell culture: multipotency and susceptibility to cell death stimuli. Cell Biol Int 37:292-304
105. George S, Heng BC, Vinoth KJ, Kishen A, Cao T (2009) Comparison of the response of human embryonic stem cells and their differentiated progenies to oxidative stress. Photomedicine Laser Surg 27:669-674
106. Drowley L, Okada M, Beckman S et al (2010) Cellular antioxidant levels influence muscle stem cell therapy. Mol Ther 18:1865-1873
107. Sehgal V, Ram PT (2013) Network Motifs in JNK Signaling. Genes & cancer 4:409-413
108. Mangi AA, Noiseux N, Kong D et al (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9:1195-1201
109. Jiang BH, Aoki M, Zheng JZ, Li J, Vogt PK (1999) Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase Akt/protein kinase B. Proc Natl Acad Sci USA 96:2077-2081
110. Fujio Y, Guo K, Mano T, Mitsuuchi Y, Testa JR, Walsh K (1999) Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival. Mol Cell Biol 19:5073-5082
111. Han D, Huang W, Ma S et al (2015) Ghrelin improves functional survival of engrafted adipose-derived mesenchymal stem cells in ischemic heart through PI3K/Akt signaling pathway. BioMed Res Int 2015:858349
112. Lin Z, Zhou P, von Gise A et al (2015) Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival. Circ Res 116:35-45
113. Vandromme M, Rochat A, Meier R et al (2001) Protein kinase B beta/Akt2 plays a specific role in muscle differentiation. J Biol Chem 276:8173-8179
114. Sussman MA, Volkers M, Fischer K et al (2011) Myocardial AKT: the omnipresent nexus. Physiol Rev 91:1023-1070
115. Matsui T, Tao J, del Monte F et al (2001) Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104:330-335
116. Shiraishi I, Melendez J, Ahn Y et al (2004) Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ Res 94:884-891
117. Gude N, Muraski J, Rubio M et al (2006) Akt promotes increased cardiomyocyte cycling and expansion of the cardiac progenitor cell population. Circ Res 99:381-388
118. Sussman M (2007) "AKT"ing lessons for stem cells: regulation of cardiac myocyte and progenitor cell proliferation. Trends Cardiovasc Med 17:235-240
119. Xu J, Liao K (2004) Protein kinase B/AKT 1 plays a pivotal role in insulin-like growth factor-1 receptor signaling induced 3T3-L1 adipocyte differentiation. J Biol Chem 279:35914-35922
120. Mukherjee A, Rotwein P (2009) Akt promotes BMP2-mediated osteoblast differentiation and bone development. J Cell Sci 122:716-726
121. Stulpinas A, Imbrasaite A, Kalvelyte AV (2012) Daunorubicin induces cell death via activation of apoptotic signalling pathway and inactivation of survival pathway in muscle-derived stem cells. Cell Biol Toxicol 28:103-114
122. McDonald GT, Sullivan R, Pare GC, Graham CH (2010) Inhibition of phosphatidylinositol 3-kinase promotes tumor cell resistance to chemotherapeutic agents via a mechanism involving delay in cell cycle progression. Exp Cell Res 316:3197-3206
123. Suvasini R, Somasundaram K (2010) Essential role of PI3-kinase pathway in p53-mediated transcription: Implications in cancer chemotherapy. Oncogene 29:3605-3618
124. Elmadbouh I, Haider H, Jiang S, Idris NM, Lu G, Ashraf M (2007) Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J Mol Cell Cardiol 42:792-803
125. Hur J, Yoon CH, Lee CS et al (2007) Akt is a key modulator of endothelial progenitor cell trafficking in ischemic muscle. Stem Cells 25:1769-1778
126. McDevitt TC, Laflamme MA, Murry CE (2005) Proliferation of cardiomyocytes derived from human embryonic stem cells is mediated via the IGF/PI 3-kinase/Akt signaling pathway. J Mol Cell Cardiol 39:865-873
127. Tateishi K, Ashihara E, Honsho S et al (2007) Human cardiac stem cells exhibit mesenchymal features and are maintained through Akt/GSK-3beta signaling. Biochem Biophys Res Commun 352:635-641
128. Otsu K, Yamashita N, Nishida K et al (2003) Disruption of a single copy of the p38alpha MAP kinase gene leads to cardioprotection against ischemia-reperfusion. Biochem Biophys Res Commun 302:56-60
129. Molkentin JD, Dorn GW 2nd (2001) Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 63:391-426
130. Rose BA, Force T, Wang Y (2010) Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 90:1507-1546
131. Chen M, Bi LL, Wang ZQ, Zhao F, Gan XD, Wang YG (2013) Time-dependent regulation of neuregulin-1beta/ErbB/ERK pathways in cardiac differentiation of mouse embryonic stem cells. Mol Cell Biochem 380:67-72
132. Kitta K, Day RM, Kim Y, Torregroza I, Evans T, Suzuki YJ (2003) Hepatocyte growth factor induces GATA-4 phosphorylation and cell survival in cardiac muscle cells. J Biol Chem 278:4705-4712
133. Parrizas M, Blakesley VA, Beitner-Johnson D, Le Roith D (1997) The proto-oncogene Crk-II enhances apoptosis by a Ras-dependent, Raf-1/MAP kinase-independent pathway. Biochem Biophys Res Commun 234:616-620
134. Sheng Z, Knowlton K, Chen J, Hoshijima M, Brown JH, Chien KR (1997) Cardiotrophin 1 (CT-1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT-1 signals for myocardial cell hypertrophy. J Biol Chem 272:5783-5791
135. De Windt LJ, Lim HW, Taigen T et al (2000) Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure. Circ Res 86:255-263
136. Iwai-Kanai E, Hasegawa K, Fujita M et al (2002) Basic fibroblast growth factor protects cardiac myocytes from iNOS-mediated apoptosis. J Cell Physiol 190:54-62
137. Dang LT, Feric NT, Laschinger C et al (2014) Inhibition of apoptosis in human induced pluripotent stem cells during expansion in a defined culture using angiopoietin-1 derived peptide QHREDGS. Biomaterials 35:7786-7799
138. Yamamoto K, Ichijo H, Korsmeyer SJ (1999) BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol Cell Biol 19:8469-8478
139. Tournier C, Hess P, Yang DD et al (2000) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288:870-874
140. Remondino A, Kwon SH, Communal C et al (2003) Beta-adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of the mitochondrial pathway. Circ Res 92:136-138
141. Andreka P, Zang J, Dougherty C, Slepak TI, Webster KA, Bishopric NH (2001) Cytoprotection by Jun kinase during nitric oxide-induced cardiac myocyte apoptosis. Circ Res 88:305-312
142. Dougherty CJ, Kubasiak LA, Prentice H, Andreka P, Bishopric NH, Webster KA (2002) Activation of c-Jun N-terminal kinase promotes survival of cardiac myocytes after oxidative stress. Biochem J 362:561-571
143. Cicconi S, Ventura N, Pastore D et al (2003) Characterization of apoptosis signal transduction pathways in HL-5 cardiomyocytes exposed to ischemia/reperfusion oxidative stress model. J Cell Physiol 195:27-37
144. Stewart CE, Newcomb PV, Holly JM (2004) Multifaceted roles of TNF-alpha in myoblast destruction: a multitude of signal transduction pathways. J Cell Physiol 198:237-247
145. Liu QC, Zha XH, Faralli H et al (2012) Comparative expression profiling identifies differential roles for Myogenin and p38alpha MAPK signaling in myogenesis. J Mol Cell Biol 4:386-397
146. Xiao F, Wang H, Fu X, Li Y, Wu Z (2012) TRAF6 promotes myogenic differentiation via the TAK1/p38 mitogen-activated protein kinase and Akt pathways. PLoS ONE 7:e34081
147. Kaiser RA, Bueno OF, Lips DJ et al (2004) Targeted inhibition of p38 mitogen-activated protein kinase antagonizes cardiac injury and cell death following ischemia-reperfusion in vivo. J Biol Chem 279:15524-15530
148. Mackay K, Mochly-Rosen D (2000) Involvement of a p38 mitogen-activated protein kinase phosphatase in protecting neonatal rat cardiac myocytes from ischemia. J Mol Cell Cardiol 32:1585-1588
149. Sharov VG, Todor A, Suzuki G, Morita H, Tanhehco EJ, Sabbah HN (2003) Hypoxia, angiotensin-II, and norepinephrine mediated apoptosis is stimulus specific in canine failed cardiomyocytes: a role for p38 MAPK, Fas-L and cyclin D1. Eur J Heart Fail 5:121-129
150. Communal C, Colucci WS, Singh K (2000) p38 mitogen-activated protein kinase pathway protects adult rat ventricular myocytes against beta -adrenergic receptor-stimulated apoptosis. Evidence for Gi-dependent activation. J Biol Chem 275:19395-19400
151. Payne KA, Meszaros LB, Phillippi JA, Huard J (2010) Effect of phosphatidyl inositol 3-kinase, extracellular signal-regulated kinases 1/2, and p38 mitogen-activated protein kinase inhibition on osteogenic differentiation of muscle-derived stem cells. Tissue Eng Part A 16:3647-3655
152. Wei H, Li Z, Hu S, Chen X, Cong X (2010) Apoptosis of mesenchymal stem cells induced by hydrogen peroxide concerns both endoplasmic reticulum stress and mitochondrial death pathway through regulation of caspases, p38 and JNK. J Cell Biochem 111:967-978
153. Evans CH, Huard J (2015) Gene therapy approaches to regenerating the musculoskeletal system. Nat Rev Rheumatol 11:234-242
154. Kim WH, Jung DW, Williams DR (2015) Making cardiomyocytes with your chemistry set: Small molecule-induced cardiogenesis in somatic cells. World J Cardiol 7:125-133
155. Pasha Z, Haider H, Ashraf M (2011) Efficient non-viral reprogramming of myoblasts to stemness with a single small molecule to generate cardiac progenitor cells. PLoS ONE 6:e23667
156. Sawyers CL (2002) Rational therapeutic intervention in cancer: kinases as drug targets. Curr Opin Genet Dev 12:111-115
157. Kyttaris VC (2012) Kinase inhibitors: a new class of antirheumatic drugs. Drug Des Dev Ther 6:245-250
158. Scatena M, Almeida M, Chaisson ML, Fausto N, Nicosia RF, Giachelli CM (1998) NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival. J Cell Biol 141:1083-1093
159. Watanabe K, Ueno M, Kamiya D et al (2007) A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 25:681-686
160. Milisav I, Ribaric S, Suput D (2015) Targeting stress responses for regenerative medicine. Methods Mol Biol 1292:235-243
161. Zhang Y, Liang X, Liao S et al (2015) Potent paracrine effects of human induced pluripotent stem cell-derived mesenchymal stem cells attenuate doxorubicin-induced cardiomyopathy. Sci Rep 5:11235
162. Wang M, Tan J, Coffey A, Fehrenbacher J, Weil BR, Meldrum DR (2009) Signal transducer and activator of transcription 3-stimulated hypoxia inducible factor-1alpha mediates estrogen receptor-alpha-induced mesenchymal stem cell vascular endothelial growth factor production. J Thorac Cardiovasc Surg 138:163-171, 171 e161.
163. Wang Y, Crisostomo PR, Wang M, Markel TA, Novotny NM, Meldrum DR (2008) TGF-alpha increases human mesenchymal stem cell-secreted VEGF by MEK- and PI3-K- but not JNK- or ERK-dependent mechanisms. Am J Physiol Regul Integr Comp Physiol 295:R1115-1123
164. Wang ZJ, Zhang FM, Wang LS, Yao YW, Zhao Q, Gao X (2009) Lipopolysaccharides can protect mesenchymal stem cells (MSCs) from oxidative stress-induced apoptosis and enhance proliferation of MSCs via Toll-like receptor(TLR)-4 and PI3K/Akt. Cell Biol Int 33:665-674
165. Yun SP, Lee MY, Ryu JM, Song CH, Han HJ (2009) Role of HIF-1alpha and VEGF in human mesenchymal stem cell proliferation by 17beta-estradiol: involvement of PKC, PI3K/Akt, and MAPKs. Am J Physiol Cell Physiol 296:C317-326
166. Fan VH, Tamama K, Au A et al (2007) Tethered epidermal growth factor provides a survival advantage to mesenchymal stem cells. Stem Cells 25:1241-1251
167. Abdelwahid E, Yokokura T, Krieser RJ, Balasundaram S, Fowle WH, White K (2007) Mitochondrial disruption in Drosophila apoptosis. Dev Cell 12:793-806
168. Tait SW, Green DR (2010) Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 11:621-632
169. Deuse T, Wang D, Stubbendorff M et al (2015) SCNT-derived ESCs with mismatched mitochondria trigger an immune response in allogeneic hosts. Cell Stem Cell 16:33-38
170. Zhu W, Chen J, Cong X, Hu S, Chen X (2006) Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells 24:416-425
171. O'Rourke B (2004) Evidence for mitochondrial K + channels and their role in cardioprotection. Circ Res 94:420-432
172. Haider H, Ashraf M (2008) Strategies to promote donor cell survival: combining preconditioning approach with stem cell transplantation. J Mol Cell Cardiol 45:554-566
173. Laflamme MA, Chen KY, Naumova AV et al (2007) Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25:1015-1024
174. Noort WA, Feye D, Van Den Akker F et al (2010) Mesenchymal stromal cells to treat cardiovascular disease: strategies to improve survival and therapeutic results. Panminerva Med 52:27-40
175. Lu G, Haider HK, Jiang S, Ashraf M (2009) Sca-1+ stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexin-43. Circulation 119:2587-2596
176. Tilkorn DJ, Davies EM, Keramidaris E et al (2012) The in vitro preconditioning of myoblasts to enhance subsequent survival in an in vivo tissue engineering chamber model. Biomaterials 33:3868-3879
177. Calabrese EJ, Bachmann KA, Bailer AJ et al (2007) Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Toxicol Appl Pharmacol 222:122-128
178. Hausenloy DJ, Yellon DM (2006) Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 70:240-253
179. Chen J, Crawford R, Chen C, Xiao Y (2013) The key regulatory roles of the PI3K/Akt signaling pathway in the functionalities of mesenchymal stem cells and applications in tissue regeneration. Tissue Eng Part B Rev 19:516-528
180. Gough DR, Cotter TG (2011) Hydrogen peroxide: a Jekyll and Hyde signalling molecule. Cell Death Dis 2:e213
181. Gao F, Hu XY, Xie XJ et al (2010) Heat shock protein 90 protects rat mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis via the PI3K/Akt and ERK1/2 pathways. J Zhejiang Univ Sci B 11:608-617
182. Cizkova D, Rosocha J, Vanicky I, Radonak J, Galik J, Cizek M (2006) Induction of mesenchymal stem cells leads to HSP72 synthesis and higher resistance to oxidative stress. Neurochem Res 31:1011-1020
183. Das B, Bayat-Mokhtari R, Tsui M et al (2012) HIF-2alpha suppresses p53 to enhance the stemness and regenerative potential of human embryonic stem cells. Stem Cells 30:1685-1695
184. Datta SR, Brunet A, Greenberg ME (1999) Cellular survival: a play in three Akts. Genes Dev 13:2905-2927
185. Jagnandan D, Church JE, Banfi B, Stuehr DJ, Marrero MB, Fulton DJ (2007) Novel mechanism of activation of NADPH oxidase 5. calcium sensitization via phosphorylation. J Biol Chem 282:6494-6507
186. Rodrigues M, Blair H, Stockdale L, Griffith L, Wells A (2013) Surface tethered epidermal growth factor protects proliferating and differentiating multipotential stromal cells from FasL-induced apoptosis. Stem Cells 31:104-116
187. Rodrigues M, Yates CC, Nuschke A, Griffith L, Wells A (2013) The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL. Tissue Eng Part A 19:1972-1983
188. Qu Q, Sun G, Murai K et al (2013) Wnt7a regulates multiple steps of neurogenesis. Mol Cell Biol 33:2551-2559
189. Bentzinger CF, von Maltzahn J, Dumont NA et al (2014) Wnt7a stimulates myogenic stem cell motility and engraftment resulting in improved muscle strength. J Cell Biol 205:97-111
190. Di Santo S, Yang Z, Wyler von Ballmoos M et al (2009) Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation. PLoS ONE 4:e5643
191. Lavasani M, Robinson AR, Lu A et al (2012) Muscle-derived stem/progenitor cell dysfunction limits healthspan and lifespan in a murine progeria model. Nat Commun 3:608
192. Jin H, Sanberg PR, Henning RJ (2013) Human umbilical cord blood mononuclear cell-conditioned media inhibits hypoxic-induced apoptosis in human coronary artery endothelial cells and cardiac myocytes by activation of the survival protein Akt. Cell Transpl 22:1637-1650
193. Shintani Y, Fukushima S, Varela-Carver A et al (2009) Donor cell-type specific paracrine effects of cell transplantation for post-infarction heart failure. J Mol Cell Cardiol 47:288-295
194. Chen TS, Lai RC, Lee MM, Choo AB, Lee CN, Lim SK (2010) Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucl Acids Res 38:215-224
195. Huang L, Ma W, Ma Y, Feng D, Chen H, Cai B (2015) Exosomes in mesenchymal stem cells, a new therapeutic strategy for cardiovascular diseases? Int J Biol Sci 11:238-245
196. Nakamura Y, Miyaki S, Ishitobi H et al (2015) Mesenchymal-stem-cell-derived exosomes accelerate skeletal muscle regeneration. FEBS Lett 589:1257-1265
197. Ibrahim AG, Cheng K, Marban E (2014) Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Rep 2:606-619
198. Lyngbaek S, Schneider M, Hansen JL, Sheikh SP (2007) Cardiac regeneration by resident stem and progenitor cells in the adult heart. Basic Res Cardiol 102:101-114
199. Mukherjee S, Lekli I, Das M, Azzi A, Das DK (2008) Cardioprotection with alpha-tocopheryl phosphate: amelioration of myocardial ischemia reperfusion injury is linked with its ability to generate a survival signal through Akt activation. Biochim Biophys Acta 1782:498-503
200. Houbaviy HB, Murray MF, Sharp PA (2003) Embryonic stem cell-specific MicroRNAs. Dev Cell 5:351-358
201. Crippa S, Cassano M, Sampaolesi M (2012) Role of miRNAs in muscle stem cell biology: proliferation, differentiation and death. Curr Pharm Des 18:1718-1729
202. Nie Y, Han BM, Liu XB et al (2011) Identification of MicroRNAs involved in hypoxia- and serum deprivation-induced apoptosis in mesenchymal stem cells. Int J Biol Sci 7:762-768
203. Guo C, Deng Y, Liu J, Qian L (2015) Cardiomyocyte-specific role of miR-24 in promoting cell survival. J Cell Mol Med 19:103-112
204. Ruan W, Xu JM, Li SB, Yuan LQ, Dai RP (2012) Effects of down-regulation of microRNA-23a on TNF-alpha-induced endothelial cell apoptosis through caspase-dependent pathways. Cardiovasc Res 93:623-632
205. Mao J, Lv Z, Zhuang Y (2014) MicroRNA-23a is involved in tumor necrosis factor-alpha induced apoptosis in mesenchymal stem cells and myocardial infarction. Exp Mol Pathol 97:23-30
206. Kim HW, Haider HK, Jiang S, Ashraf M (2009) Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J Biol Chem 284:33161-33168
207. Dakhlallah D, Zhang J, Yu L, Marsh CB, Angelos MG, Khan M (2015) MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart. J Cardiovasc Pharmacol 65:241-251
208. Glass C, Singla DK (2011) MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart. Am J Physiol Heart Circ Physiol 301:H2038-2049
209. Bao C, Guo J, Zheng M, Chen Y, Lin G, Hu M (2010) Enhancement of the survival of engrafted mesenchymal stem cells in the ischemic heart by TNFR gene transfection. Biochem Cell Biol 88:629-634
210. Bialas M, Krupka M, Janeczek A et al (2011) Transient and stable transfections of mouse myoblasts with genes coding for pro-angiogenic factors. J Physiol Pharmacol 62:219-228
211. Blumenthal B, Poppe A, Golsong P et al (2011) Functional regeneration of ischemic myocardium by transplanted cells overexpressing stromal cell-derived factor-1 (SDF-1): intramyocardial injection versus scaffold-based application. Eur J Cardio Thorac Surg 40:e135-141
212. Kutschka I, Kofidis T, Chen IY et al (2006) Adenoviral human BCL-2 transgene expression attenuates early donor cell death after cardiomyoblast transplantation into ischemic rat hearts. Circulation 114:I174-180
213. Liang X, Ding Y, Zhang Y et al (2015) Activation of NRG1-ERBB4 signaling potentiates mesenchymal stem cell-mediated myocardial repairs following myocardial infarction. Cell Death Dis 6:e1765
214. Song SW, Chang W, Song BW et al (2009) Integrin-linked kinase is required in hypoxic mesenchymal stem cells for strengthening cell adhesion to ischemic myocardium. Stem Cells 27:1358-1365
215. Henry TD, Grines CL, Watkins MW et al (2007) Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials. J Am Coll Cardiol 50:1038-1046
216. Welman T, Michel S, Segaren N, Shanmugarajah K (2015) Bioengineering for organ transplantation: progress and challenges. Bioengineered 6:257-261